CANbridge Pharmaceuticals lands $98 mn Series D
China-based CANbridge Pharmaceuticals Inc., a biopharmaceutical company, has raised $98 million in Series D financing.
China-based CANbridge Pharmaceuticals Inc., a biopharmaceutical company, has raised $98 million in Series D financing.
Copyright PEI Media
Not for publication, email or dissemination